What is Liquid I.V?
Liquid I.V. operates as a health-science nutrition and wellness company, dedicated to enhancing hydration and nutrient delivery through innovative drink mixes. Their product line, formulated in the USA, emphasizes non-GMO ingredients and the absence of artificial components. Leveraging Cellular Transport Technology (CTT), Liquid I.V. aims to accelerate the absorption of essential nutrients into the bloodstream, enabling consumers to recover and feel better more rapidly. The company's focus on science-backed wellness solutions positions it as a key player in the rapidly expanding health and performance beverage market.
How much funding has Liquid I.V raised?
Liquid I.V has raised a total of $10M across 2 funding rounds:
Series B
$5M
Series A
$5M
Series B (2018): $5M, investors not publicly disclosed
Series A (2018): $5M, investors not publicly disclosed
What's next for Liquid I.V?
The substantial enterprise-level funding, particularly the recent strategic investment, indicates that Liquid I.V. is poised for significant scaling and market expansion. This capital infusion will likely be directed towards enhancing product development, broadening distribution channels, and potentially exploring new market segments within the global wellness industry. The company's commitment to science-driven hydration solutions, coupled with this financial backing, suggests a strategic push to solidify its market leadership and capitalize on growing consumer demand for effective and convenient health supplements.
See full Liquid I.V company page
